Myeloma Research News

June 20, 2022June 20, 2022

Novel Immunotherapy QXL138AM Wins Orphan Drug Status in US

Myeloma Research News

The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to Nammi Therapeutics’ lead immunotherapy candidate QXL138AM for multiple myeloma. The first-in-class therapy is designed to kill targeted ... Read more

June 6, 2022June 6, 2022

CYT-338 Shows Anticancer Activity in Preclinical Tests

Myeloma Research News

CYT-338, an investigational myeloma therapy designed to simultaneously bind to cancer cells and activate immune cells called natural killer cells, has shown promising anti-cancer activity in preclinical studies. A team ... Read more

May 23, 2022May 23, 2022

CAR T-cell Therapy Safe, Effective in Treatment-resistant Myeloma: Study

Myeloma Research News

A CAR T-cell therapy called CART-ddBCMA that targets the protein BCMA — produced at high levels in myeloma cells — safely led to lasting responses in relapsed and refractory multiple ... Read more

May 9, 2022May 9, 2022

Ninlaro as Oral Combo Therapy Fails at Trial in Heavily Treated Patients

Myeloma Research News

Adding Ninlaro (ixazomib) to cyclophosphamide and dexamethasone does not improve progression-free survival for multiple myeloma patients who relapsed after several lines of treatment, a Phase 2 trial reported. The study, ... Read more

May 2, 2022May 2, 2022

Agreement Reached to Develop MMP-13 Inhibitors to Treat Myeloma

Myeloma Research News

SteroTherapeutics has entered into an exclusive license agreement with Moffitt Cancer Center and Florida Atlantic University Research Corporation to develop matrix metalloproteinase 13 (MMP-13) inhibitors for treating multiple myeloma. “This partnership ... Read more

April 29, 2022April 29, 2022

Organizations Rally to Help Ukrainian Rare Disease Patients

Myeloma Research News

A Russian military plane crash near Tetiana Zamorska’s home in Kyiv, Ukraine, was a sign that it was time for her and her family to leave. The treacherous, 34-hour pilgrimage that ... Read more

April 25, 2022April 25, 2022

Europe Awaits Proposed New Framework for Sharing Health Data

Myeloma Research News

The European Commission is expected to propose a new governing framework for health data next month, called the European Health Data Space (EHDS), with the aim of connecting national health ... Read more

April 18, 2022April 18, 2022

Researchers Identify Potential Antibody-based Myeloma Therapy

Myeloma Research News

Researchers in Japan have identified an antibody that binds to a myeloma-specific form of a common cell surface protein, called CD98 heavy chain, and that prolongs survival when given to ... Read more

April 14, 2022April 14, 2022

Telehealth Added to Latest Digital-friendly NORD State Report Card

COVID-19 News, Myeloma Research News

The National Organization for Rare Disorders (NORD) has updated its State Report Card to make it more digitally friendly and added telehealth to its categories of rare disease policy issues ... Read more

April 11, 2022April 11, 2022

Myeloma Action Month Reaches More Than 30M Worldwide, Foundation Says

Myeloma Research News

More than 30 million people in 46 countries joined together to participate in Myeloma Action Month (MAM), a campaign in March to raise awareness of the rare blood cancer. The ... Read more

April 4, 2022April 4, 2022

Europe’s CHMP Supports Carvykti T-cell Therapy Approval in EU

Myeloma Research News

Carvykti (ciltacabtagene autoleucel; cilta-cel) has been recommended for approval in Europe by the Committee for Medicinal Products for Human Use (CHMP), an arm of the European Medicines Agency (EMA), for ... Read more

March 30, 2022March 31, 2022

Longer Survival for Black vs White Myeloma Patients With Same Care

Myeloma Research News

Black people with multiple myeloma live longer than white patients with similar disease symptoms when both receive the same new and updated medical treatments, according to an analysis of the ... Read more

March 21, 2022March 22, 2022

Patients Have Higher COVID-19 Risk Even if Fully Vaccinated: US Study

COVID-19 News, Myeloma Research News

Even if they’re fully vaccinated, multiple myeloma patients still have an increased risk of COVID-19 infection compared with people without cancer, according to a study looking at data from more ... Read more

March 16, 2022March 16, 2022

RaDaR Serves as Starting Point for Creating Rare Disease Registry

Myeloma Research News

Patient registries are a hot topic of rare disease research and many organizations are taking advantage of this resource by signing up their patient communities and connecting with researchers. Eric ... Read more

March 14, 2022March 14, 2022

Sarclisa Extends Survival in RRMM, Long-term Phase 3 Trial Data Shows

Myeloma Research News

The therapy Sarclisa (isatuximab) extended survival by nearly seven months in relapsed/refractory multiple myeloma patients also given Pomalyst (pomalidomide) and dexamethasone as standard treatment, according to updated three-year data from the ... Read more